Ellsworth Growth and Income Fund Ltd. (NYSEAMERICAN:ECF – Get Free Report) was the recipient of a large growth in short interest during the month of April. As of April 15th, there was short interest totalling 10,200 shares, a growth of 8.5% from the March 31st total of 9,400 shares. Based on an average trading volume of 55,000 shares, the days-to-cover ratio is presently 0.2 days.
Institutional Investors Weigh In On Ellsworth Growth and Income Fund
An institutional investor recently bought a new position in Ellsworth Growth and Income Fund stock. Advisor Partners II LLC bought a new stake in Ellsworth Growth and Income Fund Ltd. (NYSEAMERICAN:ECF – Free Report) during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 40,859 shares of the investment management company’s stock, valued at approximately $329,000. Advisor Partners II LLC owned about 0.30% of Ellsworth Growth and Income Fund as of its most recent filing with the Securities & Exchange Commission. Institutional investors own 30.72% of the company’s stock.
Ellsworth Growth and Income Fund Stock Down 0.7 %
NYSEAMERICAN:ECF traded down $0.05 during trading hours on Tuesday, reaching $7.72. 44,658 shares of the stock were exchanged, compared to its average volume of 57,149. Ellsworth Growth and Income Fund has a 52 week low of $7.02 and a 52 week high of $8.91.
Ellsworth Growth and Income Fund Company Profile
Ellsworth Growth and Income Fund Ltd. is a closed-ended equity mutual fund launched by GAMCO Investors, Inc The fund is managed by Gabelli Funds, LLC. It invests in the public equity markets. The fund primarily invests in convertible securities. It invests in stocks of companies across market capitalizations.
See Also
- Five stocks we like better than Ellsworth Growth and Income Fund
- When to Sell a Stock for Profit or Loss
- NXP Semiconductors Will Set a New High Soon: $300 in Sight
- Consumer Discretionary Stocks Explained
- Hilton Demonstrates Asset Light is Right for Investors
- How to Invest in the FAANG Stocks
- Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Receive News & Ratings for Ellsworth Growth and Income Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ellsworth Growth and Income Fund and related companies with MarketBeat.com's FREE daily email newsletter.